GEORGE A. SCANGOS - 23 Oct 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol
VIR
Transactions as of
23 Oct 2024
Net transactions value
$0
Form type
4
Filing time
24 Oct 2024, 16:26:01 UTC
Previous filing
07 Jun 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 +598,270 +494% $0.000000 719,259 23 Oct 2024 Direct F1
transaction VIR Common Stock Other $0 -598,270 -34% $0.000000 1,151,730 23 Oct 2024 See footnote F1, F2
transaction VIR Common Stock Other $0 +598,270 $0.000000 598,270 23 Oct 2024 See footnote F1, F3
transaction VIR Common Stock Other $0 -598,270 -34% $0.000000 1,151,730 23 Oct 2024 See footnote F1, F4
holding VIR Common Stock 33,629 23 Oct 2024 See footnote F5
holding VIR Common Stock 179,930 23 Oct 2024 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F3 The shares are held by the spouse of the reporting person.
F4 The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
F5 The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
F6 The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.